Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and-9: Implications for chemotaxis

被引:34
作者
Denney, Helen [1 ]
Clench, Malcolm R. [1 ]
Woodroofe, M. Nicola [1 ]
机构
[1] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England
关键词
Chemokines; Processing; Chemotaxis; CCL2; CXCL10; MMP-2; MMP-9; Matrix metalloproteinase; Multiple sclerosis; Cell migration; GELATINASE-B; POSTTRANSLATIONAL MODIFICATIONS; RECEPTOR; EXPRESSION; IP-10; CXCR3; ANTAGONISTS; ENZYME; RANTES; MCP-2;
D O I
10.1016/j.bbrc.2009.02.164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteolytic processing of chemokines is a complex process that can result in dramatic effects on their chemotactic activity. Results from gel electrophoresis and mass spectrometry using recombinant CCL2 and CXCL10, incubated with either MMP-2 or -9, indicate that both chemokines are cleaved by the enzymes. N-terminal truncation of four amino acids from CCL2. and four or five residues from CXCL10 occurred, but removal of four residues from the C-terminus of CXCL10 was also observed with both MMPs. The speed of the reaction was chemokine-dependent, with N-terminal processing of CCL2 being complete within 3 h, whereas activity of the MMPs on CXCL10 remained incomplete at 48 h. The effect on the chemotactic potential of N-terminal truncation of CCL2 by MMPs-2 and -9 was investigated using in vitro migration assays. Monocytic cells exhibited a 2-fold reduction in migration to MMP-cleaved CCL2 variants, compared to intact CCL2. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 25 条
[1]   HIV blocked by chemokine antagonist [J].
ArenzanaSeisdedos, F ;
Virelizier, JL ;
Rousset, D ;
ClarkLewis, I ;
Loetscher, P ;
Moser, B ;
Baggiolini, M .
NATURE, 1996, 383 (6599) :400-400
[2]   Chemokine/chemokine receptor nomenclature [J].
Bacon, K ;
Baggiolini, M ;
Broxmeyer, H ;
Horuk, R ;
Lindley, I ;
Mantovani, A ;
Matsushima, K ;
Murphy, P ;
Nomiyama, H ;
Oppenheim, J ;
Rot, A ;
Schall, T ;
Tsang, M ;
Thorpe, R ;
Van Damme, J ;
Wadhwa, M ;
Yoshie, O ;
Zlotnik, A ;
Zoon, K .
CYTOKINE, 2003, 21 (01) :48-49
[3]   CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10) [J].
Campanella, GSV ;
Lee, EMJ ;
Sun, J ;
Luster, AD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :17066-17074
[4]   Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases [J].
Cartier, L ;
Hartley, O ;
Dubois-Dauphin, M ;
Krause, KH .
BRAIN RESEARCH REVIEWS, 2005, 48 (01) :16-42
[5]   RANTES and MCP-3 antagonists bind multiple chemokine receptors [J].
Gong, JH ;
Uguccioni, M ;
Dewald, B ;
Baggiolini, M ;
ClarkLewis, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10521-10527
[6]   Furin is a chemokine-modifying enzyme -: In vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity [J].
Hensbergen, PJ ;
Verzijl, D ;
Balog, CIA ;
Dijkman, R ;
van der Schors, RC ;
van der Raaij-Helmer, EMH ;
van der Plas, MJA ;
Leurs, R ;
Deelder, AM ;
Smit, MJ ;
Tensen, CP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (14) :13402-13411
[7]   CD26/dipeptidyl peptidase IV in context: the different roles of a multifunctional ectoenzyme in malignant transformation [J].
Iwata, S ;
Morimoto, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (03) :301-305
[8]   Matrix metalloproteinases and free radicals in cerebral ischemia [J].
Liu, KH ;
Rosenberg, GA .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (01) :71-80
[9]  
Mahad DJ, 2002, J NEUROL NEUROSUR PS, V72, P498
[10]   Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo [J].
McQuibban, GA ;
Gong, JH ;
Wong, JR ;
Wallace, JL ;
Clark-Lewis, I ;
Overall, CM .
BLOOD, 2002, 100 (04) :1160-1167